CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ache Laboratorios Farmaceuticos S.A. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ache Laboratorios Farmaceuticos S.A.
Pinheiros
Phone: +55 1126086294p:+55 1126086294 SAO PAULO, 05.426-100  Brazil Fax: +55 1126086178f:+55 1126086178

Business Summary
Ache Laboratorios Farmaceuticos SA is a Brazil-based company engaged in the pharmaceuticals production. The Company manufactures and distributes drugs, as well as is involved in the research and development of biotechnological medicines. Its product portfolio comprises prescription drugs, as well as generic and over-the-counter (OTC) medicines. The Company’s focus aims at respiratory, central nervous system, cardiology, dermatology, and oncology sector, among others. Its research area concentrates on biotechnology, phytomedicine, as well as on pharmacotechnical development. Furthermore, the Company is a parent of a range of entities, including Biosintetica Farmaceutica Ltda, Ache International Ltd, Labofarma Produtos Farmaceuticos Ltda, and Bionovis SA, among others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
---Yes-Yes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--Yes----

General Information
Outstanding Shares: 63,900,000 (As of 12/31/2016)
Fax Number: +55 1126086178


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 21, 2024